Filename: MTH PHD Thesis post minor corrections.pdf
Embargo Date:
You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy. You can contact us about this thesis . If you need to make a general enquiry, please see the Contact us page.
Graduate | Degree | Title | Advisor | MPH |
Hanbing Guo | PhD | ||
Boya Guo | PhD | ||
Adino Tsegaye | PhD | ||
Ling Guan | MS | ||
Douglas Gaitho | MPH | ||
Mariama Bah | MS | ||
Candice Wilshire | MPH | ||
Nicole Lorona | PhD | ||
Kristine Karvonen | MS | ||
Mary Casagrande | MPH | ||
Nicole Briggs | MPH | ||
Eric Bakwa | MS | ||
Zeyuan Yang | MS | ||
Ali Khaki | MS | ||
Hongjie Chen | PhD | ||
Madelyn Sather | MPH | ||
Colin Sallee | MS | ||
Gui Liu | PhD | ||
Margaret Lind | PhD | ||
Anurekha Hall | MS | ||
Matthew Goldberg | MPH | ||
Arthur Sillah | PhD | ||
David Wenger | MS | ||
Angela Steineck | MS | ||
Sarah McNabb | MPH | ||
Trenton MacAllister | MPH | ||
Cameron Haas | MPH | ||
Sophie Mayer | MS | ||
Jovana Martin | MPH | ||
Ata Moshiri | MPH | ||
Lu Chen | PhD | ||
Jessica Citronberg | PhD | ||
Richard Harbison | MS | ||
Manali Vora | MPH | ||
Emily Wu | MPH | ||
Xiaoliang Wang | PhD | ||
Julie Rivers | MS | ||
Tyler Ketterl | MS | ||
Kristina Jordahl | PhD | ||
Sebastian Jara | MPH | ||
Jamaica Robinson | PhD | ||
Barbara Harding | PhD | ||
Sharon Greene | PhD | ||
Soyeon Lippman | MS | ||
Audrey Hu | MPH | ||
Hang Yin | MS | ||
Francys Verdial Argueta | MPH | ||
Paneen Petersen | PhD | ||
Nicole Lorona | MS | ||
Feng Su | MS | ||
Jorge Soledad | MPH | ||
Colin Malone | PhD | ||
Xinwei Hua | PhD | ||
Soyeon Lippman | MS |
Sph soulcatcher, connect with us:.
© 2024 University of Washington | Seattle, WA
Home > Eppley Institute > Theses & Dissertations
Theses/dissertations from 2024 2024.
Novel Spirocyclic Dimer (SpiD3) Displays Potent Preclinical Effects in Hematological Malignancies , Alexandria Eiken
Dying Right: Supporting Anti-Cancer Therapy Through Immunogenic Cell Death , Elizabeth Schmitz
Therapeutic Effects of BET Protein Inhibition in B-cell Malignancies and Beyond , Audrey L. Smith
Identifying the Molecular Determinants of Lung Metastatic Adaptation in Prostate Cancer , Grace M. Waldron
Identification of Mitotic Phosphatases and Cyclin K as Novel Molecular Targets in Pancreatic Cancer , Yi Xiao
Development of Combination Therapy Strategies to Treat Cancer Using Dihydroorotate Dehydrogenase Inhibitors , Nicholas Mullen
Overcoming Resistance Mechanisms to CDK4/6 Inhibitor Treatment Using CDK6-Selective PROTAC , Sarah Truong
Omics Analysis in Cancer and Development , Emalie J. Clement
Investigating the Role of Splenic Macrophages in Pancreatic Cancer , Daisy V. Gonzalez
Polymeric Chloroquine in Metastatic Pancreatic Cancer Therapy , Rubayat Islam Khan
Evaluating Targets and Therapeutics for the Treatment of Pancreatic Cancer , Shelby M. Knoche
Characterization of 1,1-Diarylethylene FOXM1 Inhibitors Against High-Grade Serous Ovarian Carcinoma Cells , Cassie Liu
Novel Mechanisms of Protein Kinase C α Regulation and Function , Xinyue Li
SOX2 Dosage Governs Tumor Cell Identity and Proliferation , Ethan P. Metz
Post-Transcriptional Control of the Epithelial-to-Mesenchymal Transition (EMT) in Ras-Driven Colorectal Cancers , Chaitra Rao
Use of Machine Learning Algorithms and Highly Multiplexed Immunohistochemistry to Perform In-Depth Characterization of Primary Pancreatic Tumors and Metastatic Sites , Krysten Vance
Characterization of Metastatic Cutaneous Squamous Cell Carcinoma in the Immunosuppressed Patient , Megan E. Wackel
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling , Pauline Xu
Phos-Tag-Based Screens Identify Novel Therapeutic Targets in Ovarian Cancer and Pancreatic Cancer , Renya Zeng
Functional Characterization of Cancer-Associated DNA Polymerase ε Variants , Stephanie R. Barbari
Pancreatic Cancer: Novel Therapy, Research Tools, and Educational Outreach , Ayrianne J. Crawford
Apixaban to Prevent Thrombosis in Adult Patients Treated With Asparaginase , Krishna Gundabolu
Molecular Investigation into the Biologic and Prognostic Elements of Peripheral T-cell Lymphoma with Regulators of Tumor Microenvironment Signaling Explored in Model Systems , Tyler Herek
Utilizing Proteolysis-Targeting Chimeras to Target the Transcriptional Cyclin-Dependent Kinases 9 and 12 , Hannah King
Insights into Cutaneous Squamous Cell Carcinoma Pathogenesis and Metastasis Using a Bedside-to-Bench Approach , Marissa Lobl
Development of a MUC16-Targeted Near-Infrared Antibody Probe for Fluorescence-Guided Surgery of Pancreatic Cancer , Madeline T. Olson
FGFR4 glycosylation and processing in cholangiocarcinoma promote cancer signaling , Andrew J. Phillips
Cooperativity of CCNE1 and FOXM1 in High-Grade Serous Ovarian Cancer , Lucy Elge
Characterizing the critical role of metabolic and redox homeostasis in colorectal cancer , Danielle Frodyma
Genomic and Transcriptomic Alterations in Metabolic Regulators and Implications for Anti-tumoral Immune Response , Ryan J. King
Dimers of Isatin Derived Spirocyclic NF-κB Inhibitor Exhibit Potent Anticancer Activity by Inducing UPR Mediated Apoptosis , Smit Kour
From Development to Therapy: A Panoramic Approach to Further Our Understanding of Cancer , Brittany Poelaert
The Cellular Origin and Molecular Drivers of Claudin-Low Mammary Cancer , Patrick D. Raedler
Mitochondrial Metabolism as a Therapeutic Target for Pancreatic Cancer , Simon Shin
Development of Fluorescent Hyaluronic Acid Nanoparticles for Intraoperative Tumor Detection , Nicholas E. Wojtynek
The role of E3 ubiquitin ligase FBXO9 in normal and malignant hematopoiesis , R. Willow Hynes-Smith
BRCA1 & CTDP1 BRCT Domainomics in the DNA Damage Response , Kimiko L. Krieger
Targeted Inhibition of Histone Deacetyltransferases for Pancreatic Cancer Therapy , Richard Laschanzky
Human Leukocyte Antigen (HLA) Class I Molecule Components and Amyloid Precursor-Like Protein 2 (APLP2): Roles in Pancreatic Cancer Cell Migration , Bailee Sliker
FOXM1 Expression and Contribution to Genomic Instability and Chemoresistance in High-Grade Serous Ovarian Cancer , Carter J. Barger
Overcoming TCF4-Driven BCR Signaling in Diffuse Large B-Cell Lymphoma , Keenan Hartert
Functional Role of Protein Kinase C Alpha in Endometrial Carcinogenesis , Alice Hsu
Functional Signature Ontology-Based Identification and Validation of Novel Therapeutic Targets and Natural Products for the Treatment of Cancer , Beth Neilsen
Elucidating the Roles of Lunatic Fringe in Pancreatic Ductal Adenocarcinoma , Prathamesh Patil
Metabolic Reprogramming of Pancreatic Ductal Adenocarcinoma Cells in Response to Chronic Low pH Stress , Jaime Abrego
Understanding the Relationship between TGF-Beta and IGF-1R Signaling in Colorectal Cancer , Katie L. Bailey
The Role of EHD2 in Triple-Negative Breast Cancer Tumorigenesis and Progression , Timothy A. Bielecki
Perturbing anti-apoptotic proteins to develop novel cancer therapies , Jacob Contreras
Role of Ezrin in Colorectal Cancer Cell Survival Regulation , Premila Leiphrakpam
Evaluation of Aminopyrazole Analogs as Cyclin-Dependent Kinase Inhibitors for Colorectal Cancer Therapy , Caroline Robb
Identifying the Role of Janus Kinase 1 in Mammary Gland Development and Breast Cancer , Barbara Swenson
DNMT3A Haploinsufficiency Provokes Hematologic Malignancy of B-Lymphoid, T-Lymphoid, and Myeloid Lineage in Mice , Garland Michael Upchurch
EHD1 As a Positive Regulator of Macrophage Colony-Stimulating Factor-1 Receptor , Luke R. Cypher
Inflammation- and Cancer-Associated Neurolymphatic Remodeling and Cachexia in Pancreatic Ductal Adenocarcinoma , Darci M. Fink
Role of CBL-family Ubiquitin Ligases as Critical Negative Regulators of T Cell Activation and Functions , Benjamin Goetz
Exploration into the Functional Impact of MUC1 on the Formation and Regulation of Transcriptional Complexes Containing AP-1 and p53 , Ryan L. Hanson
DNA Polymerase Zeta-Dependent Mutagenesis: Molecular Specificity, Extent of Error-Prone Synthesis, and the Role of dNTP Pools , Olga V. Kochenova
Defining the Role of Phosphorylation and Dephosphorylation in the Regulation of Gap Junction Proteins , Hanjun Li
Molecular Mechanisms Regulating MYC and PGC1β Expression in Colon Cancer , Jamie L. McCall
Pancreatic Cancer Invasion of the Lymphatic Vasculature and Contributions of the Tumor Microenvironment: Roles for E-selectin and CXCR4 , Maria M. Steele
Altered Levels of SOX2, and Its Associated Protein Musashi2, Disrupt Critical Cell Functions in Cancer and Embryonic Stem Cells , Erin L. Wuebben
Characterization and target identification of non-toxic IKKβ inhibitors for anticancer therapy , Elizabeth Blowers
Effectors of Ras and KSR1 dependent colon tumorigenesis , Binita Das
Characterization of cancer-associated DNA polymerase delta variants , Tony M. Mertz
A Role for EHD Family Endocytic Regulators in Endothelial Biology , Alexandra E. J. Moffitt
Biochemical pathways regulating mammary epithelial cell homeostasis and differentiation , Chandrani Mukhopadhyay
EPACs: epigenetic regulators that affect cell survival in cancer. , Catherine Murari
Role of the C-terminus of the Catalytic Subunit of Translesion Synthesis Polymerase ζ (Zeta) in UV-induced Mutagensis , Hollie M. Siebler
LGR5 Activates TGFbeta Signaling and Suppresses Metastasis in Colon Cancer , Xiaolin Zhou
LGR5 Activates TGFβ Signaling and Suppresses Metastasis in Colon Cancer , Xiaolin Zhou
Genetic dissection of the role of CBL-family ubiquitin ligases and their associated adapters in epidermal growth factor receptor endocytosis , Gulzar Ahmad
Strategies for the identification of chemical probes to study signaling pathways , Jamie Leigh Arnst
Defining the mechanism of signaling through the C-terminus of MUC1 , Roger B. Brown
Targeting telomerase in human pancreatic cancer cells , Katrina Burchett
The identification of KSR1-like molecules in ras-addicted colorectal cancer cells , Drew Gehring
Mechanisms of regulation of AID APOBEC deaminases activity and protection of the genome from promiscuous deamination , Artem Georgievich Lada
Characterization of the DNA-biding properties of human telomeric proteins , Amanda Lakamp-Hawley
Studies on MUC1, p120-catenin, Kaiso: coordinate role of mucins, cell adhesion molecules and cell cycle players in pancreatic cancer , Xiang Liu
Epac interaction with the TGFbeta PKA pathway to regulate cell survival in colon cancer , Meghan Lynn Mendick
Deconvolution of the phosphorylation patterns of replication protein A by the DNA damage response to breaks , Kerry D. Brader
Modeling malignant breast cancer occurrence and survival in black and white women , Michael Gleason
The role of dna methyltransferases in myc-induced lymphomagenesis , Ryan A. Hlady
Design and development of inhibitors of CBL (TKB)-protein interactions , Eric A. Kumar
Pancreatic cancer-associated miRNAs : expression, regulation and function , Ashley M. Mohr
Mechanistic studies of mitochondrial outer membrane permeabilization (MOMP) , Xiaming Pang
Novel roles for JAK2/STAT5 signaling in mammary gland development, cancer, and immune dysregulation , Jeffrey Wayne Schmidt
Optimization of therapeutics against lethal pancreatic cancer , Joshua J. Souchek
Immune-based novel diagnostic mechanisms for pancreatic cancer , Michael J. Baine
Sox2 associated proteins are essential for cell fate , Jesse Lee Cox
KSR2 regulates cellular proliferation, transformation, and metabolism , Mario R. Fernandez
Discovery of a novel signaling cross-talk between TPX2 and the aurora kinases during mitosis , Jyoti Iyer
Regulation of metabolism by KSR proteins , Paula Jean Klutho
The role of ERK 1/2 signaling in the dna damage-induced G2 , Ryan Kolb
Regulation of the Bcl-2 family network during apoptosis induced by different stimuli , Hernando Lopez
Studies on the role of cullin3 in mitosis , Saili Moghe
Characteristics of amyloid precursor-like protein 2 (APLP2) in pancreatic cancer and Ewing's sarcoma , Haley Louise Capek Peters
Structural and biophysical analysis of a human inosine triphosphate pyrophosphatase polymorphism , Peter David Simone
Functions and regulation of Ron receptor tyrosine kinase in human pancreatic cancer and its therapeutic applications , Yi Zou
Coordinate detection of new targets and small molecules for cancer therapy , Kurt Fisher
The role of c-Myc in pancreatic cancer initiation and progression , Wan-Chi Lin
Advanced Search
Home | About | FAQ | My Account | Accessibility Statement
Privacy Copyright
All disciplines
All locations
Institution
All Institutions
All PhD Types
All Funding
Development of a multi-gene detection model for chinese luminal-type early breast cancer and its clinical translational study on the predictive value of breast cancer recurrence risk, phd research project.
PhD Research Projects are advertised opportunities to examine a pre-defined topic or answer a stated research question. Some projects may also provide scope for you to propose your own ideas and approaches.
This project has funding attached, subject to eligibility criteria. Applications for the project are welcome from all suitably qualified candidates, but its funding may be restricted to a limited set of nationalities. You should check the project and department details for more information.
Self-funded phd students only.
This project does not have funding attached. You will need to have your own means of paying fees and living costs and / or seek separate funding from student finance, charities or trusts.
Navigating barriers to breast cancer care in conflict-affected areas of the middle east and north africa (mena): a mixed-methods study, competition funded phd project (students worldwide).
This project is in competition for funding with other projects. Usually the project which receives the best applicant will be successful. Unsuccessful projects may still go ahead as self-funded opportunities. Applications for the project are welcome from all suitably qualified candidates, but potential funding may be restricted to a limited set of nationalities. You should check the project and department details for more information.
Cancer: understanding the immunosuppressive role of fibroblast and macrophages in breast cancer, cancer: characterization of egfr signaling activated by the endothelium in the process of breast cancer metastasis to the brain, unraveling the impact of epigenetic and microenvironmental factors on breast cancer development and progression, developing novel therapeutic strategies to better treat triple negative breast cancer, cancer: repurposing drugs as new treatments for breast cancer, msc by research: can ptp1b inhibition rewire macrophage function to improve anti-tumour immunity in breast cancer treatment, understanding the link between fibrosis, inflammation, and breast cancer initiation, assessing the molecular mechanisms by which cathepsin v promotes breast cancer growth and metastasis, development and application of recombinant antibodies to map pathology-related changes in glycosaminoglycans on breast cancer cells, funded phd project (uk students only).
This research project has funding attached. It is only available to UK citizens or those who have been resident in the UK for a period of 3 years or more. Some projects, which are funded by charities or by the universities themselves may have more stringent restrictions.
FindAPhD. Copyright 2005-2024 All rights reserved.
Unknown ( change )
Have you got time to answer some quick questions about PhD study?
You haven’t completed your profile yet. To get the most out of FindAPhD, finish your profile and receive these benefits:
Or begin browsing FindAPhD.com
or begin browsing FindAPhD.com
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Create your FindAPhD account and sign up to our newsletter:
Looking to list your PhD opportunities? Log in here .
Filtering Results
Key searches, alumni spotlight: meet iona cheng, phd, mph, building the evidence base in cancer research for asian americans.
(Photo courtesy Iona Cheng)
Iona Cheng, PhD, MPH, is co-leading a new study to uncover the causes of cancer in Asian Americans. Through a $12.45 million grant from the National Cancer Institute, she hopes to uncover the burden of cancer in this understudied group. Cheng received her PhD in epidemiology from the Department of Population and Public Health Sciences at the Keck School of Medicine of USC in 2005. Today, the cancer and genetic epidemiologist holds several positions including Professor of Epidemiology and Biostatistics at the University of California, San Francisco, Head of the Cancer Epidemiology Division, and Co-Investigator of the SEER Greater Bay Area Cancer Registry. “I am grateful for the training I received at USC because I learned to be curious and was taught rigorous applied epidemiologic skills that I apply to new research questions throughout my academic career,” shares Cheng.
What inspired you to pursue a career in epidemiology?
While today there is more awareness and opportunities for people to understand what epidemiology is, when I was in college there really wasn’t. After I completed my undergraduate studies, I stumbled on a course in epidemiology and enjoyed it. I gravitated towards the concept of public health and was drawn to understanding the causes of diseases at the population level versus focusing on a specific individual. I really appreciated how far-reaching epidemiology could be in terms of trying to understand health in the public at large.
Can you share with us more about your academic journey?
I received my bachelor’s degree in physiology from the University of California, Davis. After I graduated, I worked in the pharmaceutical industry for five years. I attended Yale University and received my Master of Public Health degree in Chronic Disease Epidemiology. It was during this time I decided to pursue a PhD degree. I wanted to study cancer epidemiology and understand differences across racial and ethnic populations. While sharing my interests with my advisor, she recommended looking beyond public health schools and advised me to look up the faculty at USC in the Department of Population and Public Health Science (formerly Preventive Medicine), and she was absolutely right! There was amazing research being done and several faculty had similar overlapping interests to mine. I was grateful for the recommendation because the department was not on my radar as my focus was on public health schools.
What sparked your interest in cancer research?
There’s such a personal story that people experience with cancer, and unfortunately it affects so many people. My underlying focus has always been trying to understand why a specific racial and ethnic population has a higher burden of cancer than others. I started out researching the high burden of prostate cancer in African America men. Then my interest expanded to breast, lung, and colorectal cancers.
My training at USC encouraged me to be curious and while I was formally trained in genetic epidemiology, my interests have expanded to different exposures. Today, I investigate geospatial exposures regarding neighborhood environments and environmental pollutants. I am also incorporating molecular elements to my research questions.
What was the most impactful aspect of your educational experience at USC?
I was really fortunate to have been trained by [the late] Dr. Brian Henderson and Dr. Malcolm Pike, and Dr. Anna Wu and Dr. Daniel Stram were a part of my dissertation committee. One highlight of my studies was learning about various epidemiological study designs while working with data from the Multiethnic Cohort Study—an amazing epidemiological resource. The study is based at several universities, which provided me with the opportunity to develop collaborations with other investigators, work in a large team, expand my network, and prepare me for the work I do today. As a result of my involvement, I had the opportunity to go to Boston to MIT to conduct genotyping work and laboratory training for my PhD dissertation. It was an enriching experience.
What informed your decision to pursue a career in academia?
I was motivated to continue my career in research and academia because I enjoyed designing studies and collaborating with others to ask complex research questions. I currently co-lead the Disparities, Research, Environment and Multi-omics (DREAM) lab with Drs. Scarlett Lin Gomez and Salma Shariff-Marco. We have a team of approximately 30 staff, including students and postdocs working on a portfolio of about 35 research projects largely focused on cancer health disparities and inequities. We also run the Greater Bay Area Cancer Registry, where we are responsible for the collection of cancer cases across nine counties, and other cancer surveillance projects affiliated with the registry. I’ve been fortunate to work with great teams in this line of work.
How would you say that your research has evolved?
My research has evolved to expand the research questions we ask across multiple domains. We are always trying to address questions and gaps that we see in the field and adding new layers of data to understand differences in cancer risk across population groups. I started out largely focused on genetic factors and biomarkers and have expanded to studying the neighborhood environment and environmental pollutants, with an emphasis on structural and social determinants of health. I hope in the future to incorporate elements of policy for a comprehensive approach to understand all the contributing factors.
We are thrilled about our new opportunity to establish the first Asian American cohort study of cancer etiology that is funded by the National Cancer Institute. This new cohort will address important questions in understanding cancer risk among specific Asian American ethnicities. Typically, Asian Americans have been aggregated into a collective group along with Native Hawaiian and Pacific Islanders groups.
What do you enjoy about your current role at the University of California, San Francisco?
I am energized from working with our study team. We collectively bring complimentary expertise and learn from one other. The collaboration of students, trainees and staff comprising of interviewers, biostatisticians, GIS analysts, epidemiologists, and program managers – makes for stronger research questions that we can answer together. Part of our success is having the same goal and dedication in trying to understand differences in cancer risk across population groups.
What advice do you have for students who want to follow in your footsteps?
When it comes to conducting research: always be curious, learn from your experiences, and be open to asking new questions. While academia and obtaining your own research funding is challenging, I have found that being persistent has helped me continue on this journey. Lastly, I’ve been very fortunate to have had wonderful mentorship and worked with great teams, and good collaborators are also key.
Choose a degree or diploma
22 Jun Mental Wellness Walkabout with Dr Kirti Ranchod: Understanding Brain Health Origins Centre 11:00
22 Jun lo-fi street cred: artists' zines, DIY and alternative publications Online Event 11:30
Wits In 60 Seconds
In this week's episode, Wits student Harry Saner makes history at the 2024 Paris Olympics as South Africa's first Olympic fencer since 2008, and PhD student Pedro Ornelas wins the John Kiel Scholarship. Students and staff from the Kelvin-Alexandra-Frankenwald City Studio address socio-spatial challenges in Alex and Bath Spa University funds a three-year scheme to support strategic university collaboration. Wits Chancellor Dr Judy Dlamini hosted a seminar on the global digital success of a start-up. Read more at www.wits.ac.za/news/
Wits PhD student wins prestigious John Kiel Scholarship
Wits PhD student, Pedro Ornelas, has won the prestigious John Kiel Scholarship from the International Society for Optics and Photonics (SPIE). Ornelas, a student in the Wits Structured Light Laboratory at the School of Physics won the scholarship for his work on new topological features embedded within entangled states of quantum structured light, under Professor Andrew Forbes. Ornelas’ US$ 10 000 (about R190 000) scholarship will enable him to further his research in tailoring features of classical structured light (lasers) and quantum light sources in ways to make them more robust to environmental disturbances.
Our research output has doubled in the past five years and offers new ways to impact society for good, as well as astounding ‘moonshot moments’ that give us hope and inspiration. #WitsForGood . At Wits, we produce publications of the highest quality and we work hard to sustain the interplay between teaching and research.
National Research Foundation (NRF) rated researchers of whom 26 are A-rated.
of Wits authored publications are international journals.
Increase in Wits Research output over the past five years and 72% over the last 10 years.
Specialised research entities are active in Wits.
Ask a question, ask a question successful, thanks , your question has been submitted..
Tune in to watch the broadcast.
Set reminder for
before the event starts.
Transcript request form, we've received your request.
You will be notified by email when the transcript and captions are available. The process may take up to 5 business days. Please contact [email protected] if you have any questions about this request.
Thanks for writing. We will be in touch shortly to address any questions, concerns, or technical difficulties you may have.
There are no live broadcasts scheduled.
See what's new on Cornell Video and find out what's coming up next — and how you can take part. Subscribe to receive weekly Cornell Video updates via email.
Our hamsters have processed your subscription request and advise that the weekly update messages will contain details on unsubscribing in case you need them.
Our hamsters have processed your request and advise that a summary has been sent to the email address entered.
Enter your email below to be notified when this event begins
You should receive an email confirmation shortly. We will send you an email reminder before the show begins. You may request additional reminders for other times if you wish.
You can also add this event to a calendar of your choice
For iCal, an .ics file will be downloaded to your computer or device. You may need to take additional steps to add the event to your personal calendar.
Let us know your preferences and our accommodating hamsters will snap to it!
Enter your email below to be notified when new related videos become available.
You should receive an email confirmation shortly. We will send you an email message when new related videos are posted.
IMAGES
VIDEO
COMMENTS
1.2.1 Definition. Breast cancer is a malignant tumor arising from epithelial cells of glandular milk ducts or lobules of the breast [16]. Breast carcinoma is classified as either non-invasive (carcinoma in situ) or invasive, depending on whether or not the tumor has started to grow outside the basal membrane.
Mammography can detect breast cancer at the asymptomatic phase with around 85% sensitivity and around 95% specificity (19). Since 2009 the U.S. Preventive Services Task Force recommends breast cancer screening with biennial mammograms for women age 50 to 74 years old (18, 20).
The work described in this thesis focuses on the discovery of novel candidate biomarkers for breast cancer, but also emphasize the equally important value of validating existing ones. The first study examined the expression of the protein MARCKSL1 by immunohistochemistry. Increased expression of MARCKSL1 was previously associated with risk for ...
In the United States, 13% of women are diagnosed with invasive breast cancer in their lifetime. and 6% of breast cancer patients have metastatic disease at initial diagnosis [1]. Moreover, nearly. 30% of women with early stage breast cancer will develop metastatic disease [2]. About 42,000.
Radiotherapy also reduced breast cancer mortality by 14% but increased non-breast cancer mortality by 34%. In absolute terms, this was a reduction in breast cancer mortality from 21.3% to 18.6% (difference=2.7%) and increase in non-breast cancer mortality from 3.6 to 5.4% (difference = 1.8%).
Request PDF | Ph.D. thesis : Predicting the Breast Cancer response to Chemotherapy by Image Processing and Deep Learning | Breast cancer is one of the most common diseases in women around the ...
Breast cancer (BrCa) is the second leading cause of cancer death among women, accounting for. more than 40,000 deaths each year in the United States alone[1]. While incidence has increased. over the past 5 years, outcomes have consistently improved, with a current 5-year survival rate. over 90%[2].
CHAPTER 1. INTRODUCTION 32 It includes visual and automated methods developed for assessing breast density and the most recent automated methods for quantifying risk. Chapter 6 describes the mammographic data and the evaluation methods we used for the experiments performed in the second part of the thesis.
In the search for novel prognostic and predictive biomarkers in breast cancer, microRNAs are now emerging as potential candidates. In previous studies, gene expression of miR-18a and miR-18b correlated with high proliferation and basal-like features of breast cancer. In the second study, we applied chromogenic in situ hybridization to
Collectively, this work contributes novel findings about the breast cancer immune microenvironment that may aid in precision medicine approaches for breast cancer prevention and intervention, and highlights the importance of diversity in impactful and equitable clinical research. Date of publication. 2022; Keyword. Pathology; breast cancer ...
PhD Thesis 2023. i An Investigation into the Mechanisms of Angiogenesis and Breast Cancer Metastasis Ivonne Cesarina Olivares García MD, MSc ... Breast cancer survival rates have increased over the years due to early detection and therapeutic efficacy. However, after many years of what appears to be disease-free ...
Accordingly, this dissertation proposes a new state-of-the-art CAD system for breast cancer diagnosis that is based on deep learning technology and cutting-edge computer vision techniques. Mammography screening has been recognized as the most effective tool to early detect breast lesions for reducing the mortality rate.
Haider, Marie-Therese (2016) The tumour microenvironment as a potential therapeutic target in breast cancer. PhD thesis, University of Sheffield. Metadata. Supervisors: Holen, Ingunn and Brown, Nicola: Awarding institution: ... MTH PHD Thesis post minor corrections Filename: MTH PHD Thesis post minor corrections.pdf. Licence: This work ...
Survivors of Breast Cancer Jessica Swainston A thesis submitted for the degree of Doctor of Philosophy (PhD) in the Department of Psychological Sciences Birkbeck, University of London, October 2019 . 2 Declaration 'I, Jessica Swainston, declare that the work in this submitted thesis is my own'.
cause of cancer among females worldwide and a growing public health burden in low-resource settings. As of World Health Organization (WHO) 2020 cancer country profile report, breast cancer is leading cancer in Ethiopia with the highest age standardized mortality rate of 22.9 per 100,000 population [6].
Uncovering the links between the environmental sensor, AHR, and the development of breast cancer. University of Leeds Faculty of Biological Sciences. The School of Molecular and Cellular Biology invites applications from prospective postgraduate researchers who wish to commence study for a PhD in the academic year 2023/24.
Characterizing modifiable risk factors of breast cancer recurrence and mortality in a cohort of women with luminal, triple-negative, and HER2-overexpressing breast cancer: ... PhD : Cancer incidence, mortality, and immunotherapy outcomes in relation to sleep problems: Results from Cardiovascular Health Study and a cancer immunotherapy cohort ...
Functions and regulation of Ron receptor tyrosine kinase in human pancreatic cancer and its therapeutic applications, Yi Zou. Theses/Dissertations from 2011 PDF. Coordinate detection of new targets and small molecules for cancer therapy, Kurt Fisher. PDF. The role of c-Myc in pancreatic cancer initiation and progression, Wan-Chi Lin
Breast cancer is the second most common cancer in women, surpassed only by skin cancer (National Institute of Health, 2019). In 2019, approximately 268,000 women were diagnosed with breast cancer (National Cancer Institute, 2020). Approximately seven out of a hundred women will develop breast cancer before the age of seventy (Centers for Disease
Creating effective and sustainable breast and bra education programmes for target groups. University of Portsmouth School of Sport, Health and Exercise Science. Applications are invited for a fully-funded three year PhD to commence in October 2024. . The PhD will be based in the Faculty of Science and Health, in the School of Sport, Health and ...
Development of A Next-Generation Multimodal Artificial Intelligence Platform for Early Breast Cancer Diagnosis. Queen Mary University of London Barts and The London School of Medicine and Dentistry. This Barts Charity funded project will commence in September 2024 and has funding for 4 years.
Breast Cancer Thesis Phd - Free download as PDF File (.pdf), Text File (.txt) or read online for free. The document discusses the challenges of writing a Ph.D. thesis on breast cancer, including the extensive research, analysis, and precise writing required. It notes that seeking assistance from HelpWriting.net can alleviate some of the burden by providing expert writing support throughout the ...
Pharmacologist V. Craig Jordan, Ph.D., a professor of Breast Medical Oncology and Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center who discovered Selective Estrogen Receptor Modulators (SERMs) and developed breakthrough breast cancer treatments, died June 9, 2024, at his home in Houston. He was 76 years old. Known as the "father of tamoxifen," Jordan ...
Iona Cheng, PhD, MPH, is co-leading a new study to uncover the causes of cancer in Asian Americans. Through a $12.45 million grant from the National Cancer Institute, she hopes to uncover the burden of cancer in this understudied group. Cheng received her PhD in epidemiology from the Department of Population and Public Health Sciences at the Keck School of Medicine of USC in 2005.
Violacea)on triple negative breast cancer cells This dissertation investigated C. orbiculata and Tulbaghia violacea extracts for treating triple-negative breast cancer (TNBC). Cytotoxicity assays, extensive chemical profiling, and docking studies demonstrated ... this PhD was synthesised to develop evidence-based guidelines for the support and ...
Materials Science and Engineering Recognition Ceremony 2024 ... <p></p>